Waltham, MA, United States
Waltham, MA, United States

Time filter

Source Type

In this report, the global Biosensors market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Biosensors in these regions, from 2012 to 2022 (forecast), covering United States EU China Japan South Korea Taiwan For more information or any query mail at sales@wiseguyreports.com Global Biosensors market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including Abbott Johnson &Johnson Siemens Healthineers Nova Biomedical Bayer ARKRAY Medtronic Roche Sinocare Universal Biosensors On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into Wearable Non-Wearable On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of Biosensors for each application, including Medical Environmental Monitoring Food Industry Agriculture Others If you have any special requirements, please let us know and we will offer you the report as you want. Global Biosensors Market Research Report 2017 1 Biosensors Market Overview 1.1 Product Overview and Scope of Biosensors 1.2 Biosensors Segment by Type (Product Category) 1.2.1 Global Biosensors Production and CAGR (%) Comparison by Type (Product Category) (2012-2022) 1.2.2 Global Biosensors Production Market Share by Type (Product Category) in 2016 1.2.3 Wearable 1.2.4 Non-Wearable 1.2.4 Type II 1.2.4 Type II 1.3 Global Biosensors Segment by Application 1.3.1 Biosensors Consumption (Sales) Comparison by Application (2012-2022) 1.3.2 Medical 1.3.3 Environmental Monitoring 1.3.4 Food Industry 1.3.5 Agriculture 1.3.6 Others 1.4 Global Biosensors Market by Region (2012-2022) 1.4.1 Global Biosensors Market Size (Value) and CAGR (%) Comparison by Region (2012-2022) 1.4.2 United States Status and Prospect (2012-2022) 1.4.3 EU Status and Prospect (2012-2022) 1.4.4 China Status and Prospect (2012-2022) 1.4.5 Japan Status and Prospect (2012-2022) 1.4.6 South Korea Status and Prospect (2012-2022) 1.4.7 Taiwan Status and Prospect (2012-2022) 1.5 Global Market Size (Value) of Biosensors (2012-2022) 1.5.1 Global Biosensors Revenue Status and Outlook (2012-2022) 1.5.2 Global Biosensors Capacity, Production Status and Outlook (2012-2022) 2 Global Biosensors Market Competition by Manufacturers 2.1 Global Biosensors Capacity, Production and Share by Manufacturers (2012-2017) 2.1.1 Global Biosensors Capacity and Share by Manufacturers (2012-2017) 2.1.2 Global Biosensors Production and Share by Manufacturers (2012-2017) 2.2 Global Biosensors Revenue and Share by Manufacturers (2012-2017) 2.3 Global Biosensors Average Price by Manufacturers (2012-2017) 2.4 Manufacturers Biosensors Manufacturing Base Distribution, Sales Area and Product Type 2.5 Biosensors Market Competitive Situation and Trends 2.5.1 Biosensors Market Concentration Rate 2.5.2 Biosensors Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Biosensors Capacity, Production, Revenue (Value) by Region (2012-2017) 3.1 Global Biosensors Capacity and Market Share by Region (2012-2017) 3.2 Global Biosensors Production and Market Share by Region (2012-2017) 3.3 Global Biosensors Revenue (Value) and Market Share by Region (2012-2017) 3.4 Global Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.5 United States Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.6 EU Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.7 China Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.8 Japan Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.9 South Korea Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 3.10 Taiwan Biosensors Capacity, Production, Revenue, Price and Gross Margin (2012-2017) 5 Global Biosensors Production, Revenue (Value), Price Trend by Type 5.1 Global Biosensors Production and Market Share by Type (2012-2017) 5.2 Global Biosensors Revenue and Market Share by Type (2012-2017) 5.3 Global Biosensors Price by Type (2012-2017) 5.4 Global Biosensors Production Growth by Type (2012-2017) For more information or any query mail at sales@wiseguyreports.com ABOUT US: Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of rmaket research reports under these categories and sub-categories. For more information, please visit https://www.wiseguyreports.com


News Article | April 19, 2017
Site: www.PR.com

The clinical use of biochemistry analyzers in measurement solutions such as latex agglutination, ion-selective potentiometry, and colorimetric & photometric testing. New York, NY, April 19, 2017 --( Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction. The report current values the global biochemistry analyzer market at a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%. Key Research Insights from the Report include: - The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024 - Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patient’s metabolic functions - Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America - Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR - Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers – a cost-effective upgrade to existing product line Roche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Randox Laboratories, Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd., and Nova Biomedical Corp. are profiled in the report as key players of global biochemistry analyzer market. The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers. Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR. The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024. The use of biochemistry analyzers in drug development applications is also expected to gain traction in the future. Based on modality, the report forecasts that in 2016, more than 70% of the market value was accounted by bench-top biochemistry analyzers. However, towards the end of the forecast period, the demand for bench-top modality will incur a marginal decline, while floor standing biochemistry analyzers will bring in over US$ 1,200 Mn revenues. Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/biochemistry-analyser-market.asp New York, NY, April 19, 2017 --( PR.com )-- In addition to this, accuracy of biochemistry analyzers in analyzing blood and urine samples has benefited pathology labs and diagnostic centers across the globe. Persistence Market Research predicts that the global demand for biochemistry analyzers will continue to soar on the grounds of such factors. A recent report published by Persistence Market Research projects that by the end of 2024, the global market for biochemistry analyzers will reach US$ 4,625.3 Mn in terms of value.Key findings in the report cite that the use of chemistry analyzers spans from high-throughput clinical labs to point-of-care clinics, and its use for testing enzymes, electrolytes and proteins is gaining traction. The report current values the global biochemistry analyzer market at a little over US$ 3,000 Mn. During the forecast period, revenues generated through global sales of biochemistry analyzers are, thus, expected to soar at a steady CAGR of 5.5%.Key Research Insights from the Report include:- The global market for biochemistry analyzers represents absolute $ opportunity of US$ 154.6 Mn in 2017 over 2016 and incremental opportunity of US$ 1,570.8 Mn between 2016 and 2024- Apart from clinical diagnostics, critical applications of biochemistry analyzers include drugs-of-abuse testing and diagnostic testing of patient’s metabolic functions- Over 40% of biochemistry analyzers sold across the globe during the forecast period will be concentrated in North America- Demand for biochemistry analyzers is also expected to surge in Asia-Pacific, revenues from which will record steadfast growth at 6.1% CAGR- Leading manufacturers of biochemistry analyzers are developing multiplexing analyzers – a cost-effective upgrade to existing product lineRoche Diagnostics GmbH, Siemens AG, Beckman Coulter Inc., Abbott Diagnostics Inc., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Hologic, Inc., Randox Laboratories, Ltd., Awareness Technology, Inc., Transasia Biomedicals Ltd., and Nova Biomedical Corp. are profiled in the report as key players of global biochemistry analyzer market.The report further reveals that fully-automated biochemistry analyzers will remain in great demand in the years to come. In 2017 and beyond, more than 85% of global biochemistry analyzer revenues will be accounted by sales of fully-automated biochemistry analyzers. Moreover, clinical diagnostics will also remain the largest application of biochemistry analyzers throughout the forecast period. Revenues accounted by global sales of biochemistry analyzers in clinical diagnostics are anticipated to register speedy growth at 5.7% CAGR. The report further identifies diagnostic centers as largest end-users of biochemistry analyzers in the world. On the other hand, rising number of point-of-care diagnostic labs instated in hospitals will render a key end-user of biochemistry analyzers. Together, hospitals and diagnostics centers will be responsible for procure over two-third of global biochemistry analyzers revenues through 2024.The use of biochemistry analyzers in drug development applications is also expected to gain traction in the future. Based on modality, the report forecasts that in 2016, more than 70% of the market value was accounted by bench-top biochemistry analyzers. However, towards the end of the forecast period, the demand for bench-top modality will incur a marginal decline, while floor standing biochemistry analyzers will bring in over US$ 1,200 Mn revenues.Browse Complete Report @ http://www.persistencemarketresearch.com/market-research/biochemistry-analyser-market.asp Click here to view the list of recent Press Releases from Persistence Market Research


Geographically, North America is estimated to command the largest share of the global tumor ablation market in 2016, followed by Europe. The point-of-care diagnostics market is expected to reach USD 36.96 Billion by 2021 from USD 23.16 Billion in 2016, at a CAGR of 9.8% during the forecast period. Furthermore, the report analyzes the micro markets with respect to their individual growth trends, future prospects, and contributions to the total market. Rise in prevalence of lifestyle and infectious diseases and the increasing inclination towards home healthcare across globe are key factors fueling the growth of the market across globe. Complete report on Point-of-Care Diagnostics Market spread across 221 Pages, Profiling 11 Companies and Supported with 94 Tables and 55 Figures is now available at In this report, the point-of-care diagnostics market has been segmented on the basis of product (covering glucose monitoring testing kits, cardio metabolic testing kits, infectious disease testing kits, and urinalysis testing kits, among others), mode of prescription (OTC and prescription-based testing kits), end-users (professional diagnostic centers, home care, and research laboratories), and region (North America, Europe, APAC, and RoW). All possible parameters that affect markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine percentage shares of each product in emerging nations. Report provides qualitative insights about growth rates and market drivers for all subsegments. It maps market sizes and growth rates for each subsegment and identifies segments poised for rapid growth in each geographic segment. Interested in this New Research Study Get the Sample Copy of this research In addition, healthcare decentralization, miniaturization of POC testing devices, increasing number of conferences and events, and POC tests with multiplexing capabilities are offering new growth opportunities for players in point-of-care diagnostics market. On other hand, stringent and time-consuming regulatory policies and pricing pressure owing to reimbursement cuts and budget constraints are key challenges faced by market players involved in the POC diagnostics market. Growth of overall point-of-care diagnostics market is driven by factors such as prevalence of lifestyle and infectious diseases & increasing inclination towards home healthcare across globe. Abbott Laboratories, Inc. (U.S.),Roche Diagnostics Limited (Switzerland), Siemens AG (Germany), Beckman Coulter, Inc. (U.S.),Becton, Dickinson and Company (U.S.), Johnson & Johnson (U.S.), Alere Inc. (U.S.), Instrumentation Laboratory (U.S.), PTS Diagnostics (U.S.), and Nova Biomedical (U.S.) are some of the key players in the market. Click now for more Details, Queries, Other Information and Corporate Discount this study “Point-of-Care Diagnostics Market by Products (Glucose, Cardiometabolic Monitoring, & Infectious Disease Testing Kits, Cardiac & Tumor Markers), End Users (Home, Hospitals, Ambulatory Care), Over-the- Counter & Prescription Based - Global Forecast to 2021” report @ http://www.reportsnreports.com/contacts/discount.aspx?name=278283 Geographically, North America (comprising the U.S. and Canada) is expected to command the largest share of the point-of-care diagnostics market in 2016, followed by Europe. A combination of bottom-up and top-down approaches was used to calculate market sizes and growth rates of market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. Explore more reports on Healthcare at www.reportsnreports.com/market-research/healthcare/


Global Point-of-care Testing (POCT) Market Trends and Forecast to 2024 - By Product (Blood Glucose Testing Kits, Cardiometabolic Monitoring Kits, Infectious Disease Testing Kits, Cholesterol Testing Kits, Pregnancy & Fertility Tests Kits, Tumor/Cancer Markers, Urinalysis Testing Kits, Cholesterol Test Strips, Hematology Testing Kits, Drugs Of Abuse Testing Kits, Fecal Occult Testing Kits, Rapid Coagulation Testing Kits, & Others), Prescription Mode, Distribution Channel, End User, By Geography Dallas, TX, December 16, 2016 --( The global point-of-care testing (POCT) market is segmented based on product, prescription mode, distribution channel, end user and geography. Request for sample pages: http://databridgemarketresearch.com/reports/global-point-care-testing-poct-market-trends-forecast-2024/ On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others. Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), respiratory infections testing kits, others. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit. Based on prescription mode, the market is segmented into prescription based testing and over-the-counter (OTC) testing. On the basis of distribution channel, the market is segmented into direct tenders and retail. Based on end–user the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory. Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market is further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. Read more: http://databridgemarketresearch.com/reports/global-point-care-testing-poct-market-trends-forecast-2024/ The major players operating in this market are Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, AccuBioTech Co., Ltd., bioMérieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, December 16, 2016 --( PR.com )-- The market for Global Point-of-care Testing (POCT) is expected to reach USD 38.2 billion by 2024 from USD 18.5 billion in 2016, growing 9.5% during the forecast years 2017 to 2024.The global point-of-care testing (POCT) market is segmented based on product, prescription mode, distribution channel, end user and geography.Request for sample pages: http://databridgemarketresearch.com/reports/global-point-care-testing-poct-market-trends-forecast-2024/On the basis of product the market is segmented into 13 major segments which includes blood glucose testing kits, cardiometabolic monitoring kits, infectious disease testing kits, cholesterol testing kits, pregnancy and fertility tests kits, tumor/cancer markers, urinalysis testing kits, cholesterol test strips, hematology testing kits, drugs of abuse testing kits, fecal occult testing kits, rapid coagulation testing kits, and others. Cardiometabolic Monitoring Kits are further segmented into cardiac markers, blood gas/electrolytes testing kits, HbA1c testing kits, and lipids testing. Infectious disease testing kits are further segmented into influenza testing kits, HIV testing kits, hepatitis C testing kits, sexually-transmitted diseases testing kits, tropical diseases testing kits, healthcare-associated infections), respiratory infections testing kits, others. Cholesterol testing kits are further divided into prothrombin time testing kits and activated clotting time testing kit.Based on prescription mode, the market is segmented into prescription based testing and over-the-counter (OTC) testing.On the basis of distribution channel, the market is segmented into direct tenders and retail.Based on end–user the market is segmented into hospital, clinics, ambulatory care, home healthcare, and research laboratory.Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and rest of the world. The report of this market is further segmented into 24 major countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.Read more: http://databridgemarketresearch.com/reports/global-point-care-testing-poct-market-trends-forecast-2024/The major players operating in this market are Abbott Laboratories, Inc., Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., Instrumentation Laboratory, PTS Diagnostics, Abaxis, Inc., Medtronic, Accriva Diagnostics, Opti Medical, Sienco, Inc., Alpha Scientific, AccuBioTech Co., Ltd., ACON Laboratories, Inc., Acrongenomics, AccuBioTech Co., Ltd., bioMérieux, Biomerica, Inc., Atlas Genetics Ltd., Alfa Scientific Designs, Inc., Bio-Rad Laboratories, Inc., Medica Corporation, and Nova Biomedical.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


News Article | November 23, 2016
Site: www.newsmaker.com.au

Innovations in healthcare technologies, including smartphone apps, wearable devices, lab-on-a chip, biosensors all of which offer easy link to the patient quickly becoming part of the transformation of the healthcare landscape.  The driving concept in support of point of care diagnostic is to bring testing closer to the patient and provide results appropriately and quickly. This is different technique than earlier used where all the tests were performed in the laboratory.Point of care testing has extensive application base that includes, oncology, hematology, endocrinology, prenatal testing and near patient testing in infectious disease management. Most substantial progress have taken place in the fields of oncology point of care molecular tests and infectious diseases.Rapid flu testing is a leading application for point of care platforms. Factors, such as the increasing incidences of diseases such as cardiac diseases and diabetes in developing countries, increase in the usage of home-based point of care devices, and advancement in technology with demand for development of faster and easy to use devices are energizing the point of care diagnostic market. Rising demand for home healthcare facility and the increment in population of elderly patients with multiple chronic conditions is expected to drive point of care diagnostics market over the forecast period. In light of the many factors increasing the demand for point of care diagnosis, manufacturing companies are pushing the envelope to make point of care devices faster, easier, and more reliable. Shortage of skilled-staff, especially in the field of diagnostics, are expected to restrain the market growth for point of care diagnostic. The global near patient molecular solution market is classified on the basis of technology, product type and end user. Based on technology, the global near patient molecular solution market is segmented into the following: Based on product type, the global near patient molecular solution market is segmented into the following: Based on end user, the global near patient molecular solution market is segmented into the following: Although the market of near patient diagnostic is less, but it is expected to grow over forecast period according to new healthcare analysis. It has been observed that near patient molecular solutions have witnessed higher penetration in medical system market though they facilitate better antimicrobial treatment. Point of care products for diagnosis of tuberculosis (TB), human immunodeficiency virus (HIV), hepatitis, malaria and other infectious diseases are supposed to achieve substantial growth in emerging markets. Manycompanies are developing molecular diagnostic platforms and assays that are designed to for near-patient. The initial focus of most of the medical devices companies is on infectious disease testing. Region wise, the global near patient molecular solution market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominated the global market for near patient molecular solution due to good reimbursement policies for diagnostic procedures and number of clinical studies investigating the efficiency. After North America this market is followed by Europe due to increase demand for near patient testing growth over. Asia Pacific region is expected to perceive a significantly faster growth over the forecast period due to a lower availability of hi-tech central laboratory testing facilities.Increasing number of local players providing near patient testing in countries such as China is expected to boost the market growth in APEJ region. Some of the key players in the market of near patient molecular solution are Abbott Laboratories, Inc. Roche Diagnostics Limited, Siemens AG, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson & Johnson, Alere Inc., PTS Diagnostics and Nova Biomedical. Other prominent player in near patient molecular solution market are Bayer Healthcare, BioMerieux, Bio-Rad Laboratories, Cepheid, Danaher Corporation.


News Article | February 21, 2017
Site: globenewswire.com

Dublin, Feb. 21, 2017 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of Jain PharmaBiotech's new report "Therapeutic Drug Monitoring - Technologies, Markets, and Companies" to their offering. This report deals with therapeutic drug monitoring, a multi-disciplinary clinical specialty, aimed at improving patient care by monitoring drug levels in the blood to individually adjust the dose of drugs for improving outcome. TDM is viewed as a component of personalized medicine that interacts with several other disciplines including pharmacokinetics and pharmacogenetics. One chapter is devoted to monitoring of drugs of abuse (DoA). Various technologies used for well-known DoA are described. A section on drug abuse describes methods of detection of performance-enhancing drugs. TDM market is analyzed from 2015 to 2025 according to technologies as well as geographical distribution. Global market for DoA testing was also analyzed from 2016 to 2026 and divided according to the area of application. Unmet needs and strategies for development of markets for TDM are discussed. The report contains profiles of 27 companies involved in developing tests and equipment for drug monitoring along with their collaborations. The text is supplemented with 18 tables, 6 figures and 190 selected references from literature. Benefits of this report: - Up-to-date one-stop information on therapeutic drug monitoring - Description of 27 companies involved with their collaborations in this area - Market analysis 2016-2026/ - Market values in major regions - Strategies for developing markets for therapeutic drug monitoring - A selected bibliography of 190 publications - Text is supplemented by 18 tables and 6 figures Who should read this report? - Biotechnology companies developing assays and equipment for drug monitoring - Reference laboratories providing drug monitoring services - Pharmaceutical companies interested in companion tests for monitoring their drugs - Clinical pharmacologists interested in integrating therapeutic drug monitoring with pharmacogenetics for development of personalized medicine Key Topics Covered: Executive Summary 1. Introduction Definitions Historical Landmarks in the development of TDM Pharmacology relevant to TDM Pharmacokinetics Pharmacodynamics Pharmacogenetics Pharmacogenomics Pharmacoproteomics Drug receptors Protein binding Therapeutic range of a drug Variables that affect TDM Indications for TDM Multidisciplinary nature of TDM 2. Technologies for TDM Introduction Sample preparation Proteomic technologies Mass spectrometry Liquid chromatography MS Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry Combining capillary electrophoresis with MS Gas-liquid chromatography Tissue imaging mass spectrometry New trends in sample preparation Pressure Cycling Technology Desorption electrospray ionization imaging High Performance Liquid Chromatography (HPLC) Ultra performance LC TDM using dry blood spots Analysis of dried blood spots for drugs using DESI Quantitative analysis of drugs in dried blood spot by paper spray MS Immunoassays Enzyme-linked immunosorbent assay Cloned Enzyme Donor Immunoassay Enzyme Multiplied Immunoassay Technique Fluorescence Polarization Immunoassay Particle Enhanced Turbidimetric Inhibition Immunoassay Radioimmunometric assays Biosensors Nanosensors Biochips & Microarrays Introduction Microchip capillary electrophoresis Phototransistor biochip biosensor Microchip-based fluorescence polarization immunoassay for TDM Cellular microarrays Microfluidics for TDM Lab-on-a-chip Micronics' microfluidic technology Rheonix CARD technology Nano-interface in a microfluidic chip Levitation of nanofluidic drops with physical forces Nanoarrays Nanobiotechology NanoDx Biomarkers Applications of biomarkers in drug safety studies Genomic technologies for toxicology biomarkers Proteomic technologies for toxicology biomarkers Metabonomic technologies for toxicology biomarkers Integration of genomic and metabonomic data to develop toxicity biomarkers Toxicology studies based on biomarkers Biomarkers of hepatotoxicity Biomarkers of nephrotoxicity Cardiotoxicity Neurotoxicity Biomarkers in clinical trials Molecular diagnostics 3. Drug Monitoring Instruments Introduction Description of important instruments AB SCIEX instruments AB SCIEX LC/MS/MS Abbott instruments ARCHITECT c16000 ARCHITECT c4000 ARCHITECT c8000 ARCHITECT ci16200 Integrated System ARCHITECT ci4100 Integrated System ARCHITECT ci8200 integrated with the ARCHITECT i2000SR ARCHITECT i1000SR ARCHITECT i4000SR AxSYM Agilent's 6400 Series Triple Quadrupole LC/MS Alfa Wassermann's ACE Alera AMS Diagnostics' LIASYS Awareness Technology's STAT FAX 4500 Beckman Coulter instruments Beckman Coulter Unicel Series AU5800 automated chemistry systems AU480 Binding Site ESP600 bioMerieux Mini Vidas Carolina BioLis 24i Chromsystems' HPLC instruments Grifols Triturus ABX Pentra 400 Medica EasyRA Nova Biomedical Critical Care Xpress Ortho Clinical Diagnostics' VITROS® family of systems Immunodiagnostic systems Randox intruments Randox RX Imola Roche instruments Cobas® 8000 COBAS INTEGRA® Systems Siemens instruments ADVIA 1200 ADVIA Centaur XP immunoassay system EMIT® II Plus Syva® Viva® Drug Testing Systems Dimension® Xpand® Plus Integrated Chemistry System Thermo Scientific instruments Indiko Tosoh AIA-Series 4. Applications of TDM Introduction Pharmaceutical research and drug development Clinical trials Computerized clinical decision support systems for TDM and dosing Medication-related interferences with measurements of catecholamines Polymorphisms of genes affecting drug metabolism TDM for drug safety TDM in special groups The aged Children Pregnancy TDM of prophylactic therapy Monitoring of vitamin D levels Monitoring of RBC folic acid levels during pregancy Personalized medicine Role of TDM in personalized medicine Applications according to various conditions Anesthesia and critical care Optimizing antimicrobial dosing for critically ill patients TDM monitoring of thiopental continuous infusion in critical care Role of TDM in critical care cardiac patients. Cancer Epilepsy Personalized approach to use of AEDs Infections Virus infections Fungal infections Pain management Role of TDM in pain management Monitoring of analgesic drugs in urine samples AEDs as analgesics Triptans for migraine Psychiatric disorders Guidelines for use of TDM in psychiatric patients TDM of psychotropic drugs Transplantation TDM of Tacrolismus in transplantation TDM of cyclosporine A in transplantation Monitoring of immunosuppression with mycophenolate mofetil Emergency toxicology Future prospects of TDM 5. Drugs Requiring Monitoring Introduction Antiepileptics Carbamazepine TDM of carbamazepine Gabapentin Lacosamide Lamotrigine TDM of lamotrigine Levetiracetam TDM of levetiracetam Phenobarbital TDM of phenobarbital Phenytoin TDM of phenytoin Primidone TDM of primidone Topiramate TDM of topiramate Valproic acid TDM of valproic acid TDM of multiple antiepileptic drugs in plasma/serum Antimicrobials Antibiotics Amikacin Anti-tuberculosis drugs Chloramphenicol Gentamicin Tobramycin Vancomycin Norvancomycin Antiviral agents Anti-HIV drugs Antifungal agents Voriconazole Antidepressants TDM of selective serotonin reuptake inhibitors Antipsychotics Aripiprazole Quetiapine TDM of risperidone TDM of AEDs in psychiatric disorders TDM of multiple drugs in psychiatry Bronchodilators Theophylline Cardiovascular drugs Antiarrhythmic drugs Anticoagulants Dabigatran Antihypertensive drugs ß-blockers Cardiotonic drugs Digoxin TDM of statins for hypercholesterolemia Chemotherapy for cancer TDM of 5-FU TDM of Methotrexate TDM of imitanib Drugs used for treatment of Alzheimer disease Donepezil Galantamine Memantine Drugs used for treatment of Parkinson disease Monitoring of levodopa and carbidopa therapy Catechol-O-methyltransferase inhibitors Drugs for treatment of attention-deficit hyperactivity disorder Atomoxetine Methylphenidate Hypnotic-sedative drugs Benzodiazepines Propofol Immunosuppressive drugs TDM of mycophenolic acid for the treatment of lupus nephritis Steroids Prednisone Miscellaneous drugs Azathioprine Sildenafil 6. Monitoring of Biological Therapies Introduction Cell therapy In vivo tracking of cells Molecular imaging for tracking cells MRI technologies for tracking cells Superparamagnetic iron oxide nanoparticles as MRI contrast agents Visualization of gene expression in vivo by MRI Gene therapy Application of molecular diagnostic methods in gene therapy Use of PCR to study biodistribution of gene therapy vector PCR for verification of the transcription of DNA In situ PCR for direct quantification of gene transfer into cells Detection of retroviruses by reverse transcriptase (RT)-PCR Confirmation of viral vector integration Monitoring of gene expression Monitoring of gene expression by green fluorescent protein Monitoring in vivo gene expression by molecular imaging Monoclonal antibodies Natalizumab 7. Monitoring of Drug Abuse Introduction Tests used for detection of drug abuse Forensic applications of detection of illicit drugs in fingerprints by MALDI MS MS for doping control Randox assays for DoA Drugs of Abuse Array V Urine drug testing TDM of drugs for treatment of substance abuse-related disorders Drug testing to monitor treatment of drug abuse Minimum requirement for drug testing in patients Analgesic abuse ?-blockers as doping agents Detection of ß-blockers in urine Chronic alcohol abuse Cocaine CEDIA for cocaine in human serum Detection of cocaine molecules by nanoparticle-labeled aptasensors Infrared spectroscopy for detection of cocaine in saliva Marijuana Use of marijuana and synthetic cannabinoids Detection of cannabinoids ELISA for detection of synthetic cannabinoids Drug abuse for performance enhancement in sports Historical aspects of drug abuse in sports Drugs used by athletes for performance enhancement Techniques used for detection of drug abuse by athletes Mass spectrometry for detection of peptide hormones miRNAs for the detection of erythropoiesis-stimulating agents Detection of anabolic steroids Body fluids and tissues used for detection of drug abuse in sports Urine drug testing Spray (sweat) drug test kits Hair drug testing Gene doping in sports Gene transfer methods used for enhancing physical performance Misuse of cell therapy in sport Challenges of detecting genetic manipulations in athletes Drug abuse testing in race horses Limitations and future prospects Role of pharmaceutical industry in anti-doping testing 8. Markets for TDM Introduction Methods for market estimation and future forecasts Markets for TDM tests Markets for TDM and DoA testing equipment Geographical distribution of markets for TDM tests Drivers for growth of TDM markets Markets for DoA testing Unmet needs in TDM Cost-benefit studies Simplifying assays and reducing time and cost Strategies for developing markets Physician education Supporting research on TDM Biomarker patents for drug monitoring 9. Companies Profiles of companies Collaborations 10. References For more information about this report visit http://www.researchandmarkets.com/research/g4tq2x/therapeutic_drug


News Article | November 3, 2016
Site: www.newsmaker.com.au

This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering  Abaxis  Abbott Labs  Accriva  ACON  Alere  Arkray  Beckman Coulter  bioMerieux SA  Church & Dwight  Eiken Chemical  EKF Diagnostics  Enterix  Helena Labs  Insight Pharmaceutical  Instrumentation Laboratories  LifeScan  Macherey-Nagel  Meridian BioScience  Nova Biomedical  OPKO Health  OraSure  Ortho Clinical Diagnostics  Polymed Therapeutics  Polymer Technologies  Quidel  Radiometer Medical  Response Biomedical  Roche Diagnostics  Siemens Healthcare  Sysmex By types, the market can be split into  Type I  Type II  Type III By Application, the market can be split into  Patient Professional Monitoring  Patient Self-Monitoring  Application 3 By Regions, this report covers (we can add the regions/countries as you want)  North America  China  Europe  Southeast Asia  Japan  India Global POC Diagnostics Market Professional Survey Report 2016  1 Industry Overview of POC Diagnostics  1.1 Definition and Specifications of POC Diagnostics  1.1.1 Definition of POC Diagnostics  1.1.2 Specifications of POC Diagnostics  1.2 Classification of POC Diagnostics  1.2.1 Type I  1.2.2 Type II  1.2.3 Type III  1.3 Applications of POC Diagnostics  1.3.1 Patient Professional Monitoring  1.3.2 Patient Self-Monitoring  1.3.3 Application 3  1.4 Market Segment by Regions  1.4.1 North America  1.4.2 China  1.4.3 Europe  1.4.4 Southeast Asia  1.4.5 Japan  1.4.6 India 8 Major Manufacturers Analysis of POC Diagnostics  8.1 Abaxis  8.1.1 Company Profile  8.1.2 Product Picture and Specifications  8.1.2.1 Type I  8.1.2.2 Type II  8.1.2.3 Type III  8.1.3 Abaxis 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.1.4 Abaxis 2015 POC Diagnostics Business Region Distribution Analysis  8.2 Abbott Labs  8.2.1 Company Profile  8.2.2 Product Picture and Specifications  8.2.2.1 Type I  8.2.2.2 Type II  8.2.2.3 Type III  8.2.3 Abbott Labs 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.2.4 Abbott Labs 2015 POC Diagnostics Business Region Distribution Analysis  8.3 Accriva  8.3.1 Company Profile  8.3.2 Product Picture and Specifications  8.3.2.1 Type I  8.3.2.2 Type II  8.3.2.3 Type III  8.3.3 Accriva 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.3.4 Accriva 2015 POC Diagnostics Business Region Distribution Analysis  8.4 ACON  8.4.1 Company Profile  8.4.2 Product Picture and Specifications  8.4.2.1 Type I  8.4.2.2 Type II  8.4.2.3 Type III  8.4.3 ACON 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.4.4 ACON 2015 POC Diagnostics Business Region Distribution Analysis  8.5 Alere  8.5.1 Company Profile  8.5.2 Product Picture and Specifications  8.5.2.1 Type I  8.5.2.2 Type II  8.5.2.3 Type III  8.5.3 Alere 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.5.4 Alere 2015 POC Diagnostics Business Region Distribution Analysis  8.6 Arkray  8.6.1 Company Profile  8.6.2 Product Picture and Specifications  8.6.2.1 Type I  8.6.2.2 Type II  8.6.2.3 Type III  8.6.3 Arkray 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.6.4 Arkray 2015 POC Diagnostics Business Region Distribution Analysis  8.7 Beckman Coulter  8.7.1 Company Profile  8.7.2 Product Picture and Specifications  8.7.2.1 Type I  8.7.2.2 Type II  8.7.2.3 Type III  8.7.3 Beckman Coulter 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.7.4 Beckman Coulter 2015 POC Diagnostics Business Region Distribution Analysis  8.8 bioMerieux SA  8.8.1 Company Profile  8.8.2 Product Picture and Specifications  8.8.2.1 Type I  8.8.2.2 Type II  8.8.2.3 Type III  8.8.3 bioMerieux SA 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.8.4 bioMerieux SA 2015 POC Diagnostics Business Region Distribution Analysis  8.9 Church & Dwight  8.9.1 Company Profile  8.9.2 Product Picture and Specifications  8.9.2.1 Type I  8.9.2.2 Type II  8.9.2.3 Type III  8.9.3 Church & Dwight 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.9.4 Church & Dwight 2015 POC Diagnostics Business Region Distribution Analysis  8.10 Eiken Chemical  8.10.1 Company Profile  8.10.2 Product Picture and Specifications  8.10.2.1 Type I  8.10.2.2 Type II  8.10.2.3 Type III  8.10.3 Eiken Chemical 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.10.4 Eiken Chemical 2015 POC Diagnostics Business Region Distribution Analysis  8.11 EKF Diagnostics  8.11.1 Company Profile  8.11.2 Product Picture and Specifications  8.11.2.1 Type I  8.11.2.2 Type II  8.11.2.3 Type III  8.11.3 EKF Diagnostics 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.11.4 EKF Diagnostics 2015 POC Diagnostics Business Region Distribution Analysis  8.12 Enterix  8.12.1 Company Profile  8.12.2 Product Picture and Specifications  8.12.2.1 Type I  8.12.2.2 Type II  8.12.2.3 Type III  8.12.3 Enterix 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.12.4 Enterix 2015 POC Diagnostics Business Region Distribution Analysis  8.13 Helena Labs  8.13.1 Company Profile  8.13.2 Product Picture and Specifications  8.13.2.1 Type I  8.13.2.2 Type II  8.13.2.3 Type III  8.13.3 Helena Labs 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.13.4 Helena Labs 2015 POC Diagnostics Business Region Distribution Analysis  8.14 Insight Pharmaceutical  8.14.1 Company Profile  8.14.2 Product Picture and Specifications  8.14.2.1 Type I  8.14.2.2 Type II  8.14.2.3 Type III  8.14.3 Insight Pharmaceutical 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.14.4 Insight Pharmaceutical 2015 POC Diagnostics Business Region Distribution Analysis  8.15 Instrumentation Laboratories  8.15.1 Company Profile  8.15.2 Product Picture and Specifications  8.15.2.1 Type I  8.15.2.2 Type II  8.15.2.3 Type III  8.15.3 Instrumentation Laboratories 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.15.4 Instrumentation Laboratories 2015 POC Diagnostics Business Region Distribution Analysis  8.16 LifeScan  8.16.1 Company Profile  8.16.2 Product Picture and Specifications  8.16.2.1 Type I  8.16.2.2 Type II  8.16.2.3 Type III  8.16.3 LifeScan 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.16.4 LifeScan 2015 POC Diagnostics Business Region Distribution Analysis  8.17 Macherey-Nagel  8.17.1 Company Profile  8.17.2 Product Picture and Specifications  8.17.2.1 Type I  8.17.2.2 Type II  8.17.2.3 Type III  8.17.3 Macherey-Nagel 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.17.4 Macherey-Nagel 2015 POC Diagnostics Business Region Distribution Analysis  8.18 Meridian BioScience  8.18.1 Company Profile  8.18.2 Product Picture and Specifications  8.18.2.1 Type I  8.18.2.2 Type II  8.18.2.3 Type III  8.18.3 Meridian BioScience 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.18.4 Meridian BioScience 2015 POC Diagnostics Business Region Distribution Analysis  8.19 Nova Biomedical  8.19.1 Company Profile  8.19.2 Product Picture and Specifications  8.19.2.1 Type I  8.19.2.2 Type II  8.19.2.3 Type III  8.19.3 Nova Biomedical 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.19.4 Nova Biomedical 2015 POC Diagnostics Business Region Distribution Analysis  8.20 OPKO Health  8.20.1 Company Profile  8.20.2 Product Picture and Specifications  8.20.2.1 Type I  8.20.2.2 Type II  8.20.2.3 Type III  8.20.3 OPKO Health 2015 POC Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis  8.20.4 OPKO Health 2015 POC Diagnostics Business Region Distribution Analysis  8.21 OraSure  8.22 Ortho Clinical Diagnostics  8.23 Polymed Therapeutics  8.24 Polymer Technologies  8.25 Quidel  8.26 Radiometer Medical  8.27 Response Biomedical  8.28 Roche Diagnostics  8.29 Siemens Healthcare  8.30 Sysmex


This report studies sales (consumption) of Blood Gas and Electrolyte Analysers in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering Medica Nova Biomedical Roche Samsung Medison Siemens Healthcare Jokoh Perlong Medical Radiometer View Full Report With Complete TOC, List Of Figure and Table: http://globalqyresearch.com/united-states-blood-gas-and-electrolyte-analysers-market-report-2016 Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into Type I Type II Type III Split by applications, this report focuses on sales, market share and growth rate of Blood Gas and Electrolyte Analysers in each application, can be divided into Application 1 Application 2 Application 3 United States Blood Gas and Electrolyte Analysers Market Report 2016 1 Blood Gas and Electrolyte Analysers Overview 1.1 Product Overview and Scope of Blood Gas and Electrolyte Analysers 1.2 Classification of Blood Gas and Electrolyte Analysers 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Application of Blood Gas and Electrolyte Analysers 1.3.1 Application 1 1.3.2 Application 2 1.3.3 Application 3 1.4 United States Market Size Sales (Value) and Revenue (Volume) of Blood Gas and Electrolyte Analysers (2011-2021) 1.4.1 United States Blood Gas and Electrolyte Analysers Sales and Growth Rate (2011-2021) 1.4.2 United States Blood Gas and Electrolyte Analysers Revenue and Growth Rate (2011-2021) 5 United States Blood Gas and Electrolyte Analysers Manufacturers Profiles/Analysis 5.1 Medica 5.1.1 Company Basic Information, Manufacturing Base and Competitors 5.1.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.1.2.1 Type I 5.1.2.2 Type II 5.1.3 Medica Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.1.4 Main Business/Business Overview 5.2 Nova Biomedical 5.2.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.2.2.1 Type I 5.2.2.2 Type II 5.2.3 Nova Biomedical Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.2.4 Main Business/Business Overview 5.3 Roche 5.3.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.3.2.1 Type I 5.3.2.2 Type II 5.3.3 Roche Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.3.4 Main Business/Business Overview 5.4 Samsung Medison 5.4.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.4.2.1 Type I 5.4.2.2 Type II 5.4.3 Samsung Medison Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.4.4 Main Business/Business Overview 5.5 Siemens Healthcare 5.5.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.5.2.1 Type I 5.5.2.2 Type II 5.5.3 Siemens Healthcare Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.5.4 Main Business/Business Overview 5.6 Jokoh 5.6.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.6.2.1 Type I 5.6.2.2 Type II 5.6.3 Jokoh Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.6.4 Main Business/Business Overview 5.7 Perlong Medical 5.7.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.7.2.1 Type I 5.7.2.2 Type II 5.7.3 Perlong Medical Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.7.4 Main Business/Business Overview 5.8 Radiometer 5.8.2 Blood Gas and Electrolyte Analysers Product Type, Application and Specification 5.8.2.1 Type I 5.8.2.2 Type II 5.8.3 Radiometer Blood Gas and Electrolyte Analysers Sales, Revenue, Price and Gross Margin (2011-2016) 5.8.4 Main Business/Business Overview Global QYResearch ( http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.


News Article | November 16, 2016
Site: www.newsmaker.com.au

WiseGuyReports.Com Publish a New Market Research Report On – “Self-Care Medical Devices 2016 Global Market Share,Growth,Trends & Forecast to 2020”. This market research study offers a comprehensive analysis of the global self-care medical devices market by application (SMBG, peritoneal dialysis, sleep apnea, insulin pumps, body temperature monitors, inhalers, pedometers, blood pressure monitors, nebulizers, male external catheters, and Holter monitors), and by geography (the Americas, APAC, and EMEA). Major vendors in this market are Abbott, Johnson & Johnson (J&J), Medtronic, Omron, Philips, and Roche Diagnostics. Overview of the global self-care medical devices market  The market research analyst predicts that the global self-care devices market will grow at a steady CAGR of approximately 9% during the forecast period. Factors such as public awareness have resulted in the need for self-care devices. Increased knowledge of one’s heath condition and the advantages of using devices like insulin pumps and glucose monitors have played a significant role in market demand. Moreover, device manufacturers are focused on offering easy to use and portable devices so that patients can take a more active role in monitoring their health. Additionally, awareness programs by various medical associations will help to increase the market growth of self-care medical devices during the forecast period. For more information or any query mail at [email protected] Advances in technology have played a significant role in product innovation and also ease of use. Current market trends show that wearable technology has made it easier for consumers to not only use devices regularly but also monitor their health status. For instance, insulin pumps have changed significantly over the last decade. These pumps help to deliver the right amount of glucose to a diabetic and stop when the threshold is reached. Sensors continually monitor a patient and indicate low blood glucose levels. Such advancements are expected to fuel the growth of the devices market for many health conditions during the forecast period. Segmentation by application and analysis of the self-care medical devices market  -Self-monitoring of blood glucose (SMBG)  -Peritoneal dialysis  -Sleep apnea  -Insulin pumps  -Body temperature monitors  -Inhalers  -Pedometers  -Blood pressure monitors  -Nebulizers  -Male external catheters  -Holter monitors During 2015, the SMBG devices segment of the self-care devices market accounted for the largest market share and is expected to generate revenues of close to USD 17 billion by the end of the forecast period. An increased incidence of diabetes in adults and children alike globally is driving the demand for more SMBG devices. Geographical segmentation and analysis of the self-care medical devices market  -Americas  -APAC  -EMEA The global self-care medical care devices market will be dominated by the Americas with a market share of close to 46%. Factors fueling market growth are health issues like diabetes, respiratory disorders, incontinence among the elderly and other chronic illnesses. Ordering these devices is very easy due to online retailing, increased consumer awareness and reimbursement for use by insurance carriers. Moreover, the sales of self-monitoring medical devices products in the US have increased due to the growing awareness about chronic diseases such as CVDs, CKD, diabetes, ERSD, and obesity, which had led many individuals to undergo regular tests and check-ups. Competitive landscape and key vendors  The self-care medical devices market is saturated with the presence of many international and regional vendors. Regional players are finding it difficult to compete with well-established vendors due to factors like price, technology and product quality. Competition is expected to intensify on the basis of product extensions, innovation and mergers. Key vendors in this market are - Other prominent vendors in this market are Animas, Arkray, B. Braun Melsungen, Baxter, BioDerm, Bionime, Bioptik Technology, Chongqing Haray International Business, Coloplast, Consort Medical, DaVita Healthcare, Dexcom, Diversified Specialty Institue Holdings, Fitbit, Garmin, Gerresheimer, Gluco-Ease, GlySens, Grove Instruments, Hollister, Huaren Pharmaceutical, IA Collaborative, Insulet, Integrity Applications, Jawbone, LabStyle Innovations, LifeWatch DigiTrack, M Pharmaceutical, Medical Components, Medisana, MicroPort, MidMark, Mortara Instrument, Nike, Nipro, Nipro Diagnostics, Nova Biomedical, NxStage Medical, NYPRO, OrSense, PARI Medical Holding, QRS Diagnostic, RPC BRAMLAGE, Scottcare, Senseonics, Sterimed, Sunrising Enterprise, Tandem, Tekcapital, Valeritas, Welch Allyn, and Wuhan HNC Technology. Key questions answered in the report include  -What will the market size and the growth rate be in 2020?  -What are the key factors driving the global self-care medical devices market?  -What are the key market trends impacting the growth of the global self-care medical devices market?  -What are the challenges to market growth?  -Who are the key vendors in the global self-care medical devices market?  -What are the market opportunities and threats faced by the vendors in the global self-care medical devices market?  -Trending factors influencing the market shares of the Americas, APAC, and EMEA.  -What are the key outcomes of the five forces analysis of the global self-care medical devices market? For more information or any query mail at [email protected] Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports features an exhaustive list of market research reports from hundreds of publishers worldwide. We boast a database spanning virtually every market category and an even more comprehensive collection of market research reports under these categories and sub-categories.


This report studies Global Blood Metabolites Market 2016, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering Eschweiler Roche Alere Meizhou Cornley Hi-Tech Nova Biomedical Samsung Optocell Technology Zef Scientific Radiometer Convergent Technologies By types, the market can be split into Type I Type II Type III By Application, the market can be split into Hospitals Laboratory Other Medical Institutions By Regions, this report covers (we can add the regions/countries as you want) North America China Europe Southeast Asia Japan India Global Blood Metabolites Market Professional Survey Report 2016 1 Industry Overview of Blood Metabolites 1.1 Definition and Specifications of Blood Metabolites 1.1.1 Definition of Blood Metabolites 1.1.2 Specifications of Blood Metabolites 1.2 Classification of Blood Metabolites 1.2.1 Type I 1.2.2 Type II 1.2.3 Type III 1.3 Applications of Blood Metabolites 1.3.1 Hospitals 1.3.2 Laboratory 1.3.3 Other Medical Institutions 1.4 Market Segment by Regions 1.4.1 North America 1.4.2 China 1.4.3 Europe 1.4.4 Southeast Asia 1.4.5 Japan 1.4.6 India 8 Major Manufacturers Analysis of Blood Metabolites 8.1 Eschweiler 8.1.1 Company Profile 8.1.2 Product Picture and Specifications 8.1.2.1 Type I 8.1.2.2 Type II 8.1.2.3 Type III 8.1.3 Eschweiler 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.1.4 Eschweiler 2015 Blood Metabolites Business Region Distribution Analysis 8.2 Roche 8.2.1 Company Profile 8.2.2 Product Picture and Specifications 8.2.2.1 Type I 8.2.2.2 Type II 8.2.2.3 Type III 8.2.3 Roche 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.2.4 Roche 2015 Blood Metabolites Business Region Distribution Analysis 8.3 Alere 8.3.1 Company Profile 8.3.2 Product Picture and Specifications 8.3.2.1 Type I 8.3.2.2 Type II 8.3.2.3 Type III 8.3.3 Alere 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.3.4 Alere 2015 Blood Metabolites Business Region Distribution Analysis 8.4 Meizhou Cornley Hi-Tech 8.4.1 Company Profile 8.4.2 Product Picture and Specifications 8.4.2.1 Type I 8.4.2.2 Type II 8.4.2.3 Type III 8.4.3 Meizhou Cornley Hi-Tech 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.4.4 Meizhou Cornley Hi-Tech 2015 Blood Metabolites Business Region Distribution Analysis 8.5 Nova Biomedical 8.5.1 Company Profile 8.5.2 Product Picture and Specifications 8.5.2.1 Type I 8.5.2.2 Type II 8.5.2.3 Type III 8.5.3 Nova Biomedical 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.5.4 Nova Biomedical 2015 Blood Metabolites Business Region Distribution Analysis 8.6 Samsung 8.6.1 Company Profile 8.6.2 Product Picture and Specifications 8.6.2.1 Type I 8.6.2.2 Type II 8.6.2.3 Type III 8.6.3 Samsung 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.6.4 Samsung 2015 Blood Metabolites Business Region Distribution Analysis 8.7 Optocell Technology 8.7.1 Company Profile 8.7.2 Product Picture and Specifications 8.7.2.1 Type I 8.7.2.2 Type II 8.7.2.3 Type III 8.7.3 Optocell Technology 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.7.4 Optocell Technology 2015 Blood Metabolites Business Region Distribution Analysis 8.8 Zef Scientific 8.8.1 Company Profile 8.8.2 Product Picture and Specifications 8.8.2.1 Type I 8.8.2.2 Type II 8.8.2.3 Type III 8.8.3 Zef Scientific 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.8.4 Zef Scientific 2015 Blood Metabolites Business Region Distribution Analysis 8.9 Radiometer 8.9.1 Company Profile 8.9.2 Product Picture and Specifications 8.9.2.1 Type I 8.9.2.2 Type II 8.9.2.3 Type III 8.9.3 Radiometer 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.9.4 Radiometer 2015 Blood Metabolites Business Region Distribution Analysis 8.10 Convergent Technologies 8.10.1 Company Profile 8.10.2 Product Picture and Specifications 8.10.2.1 Type I 8.10.2.2 Type II 8.10.2.3 Type III 8.10.3 Convergent Technologies 2015 Blood Metabolites Sales, Ex-factory Price, Revenue, Gross Margin Analysis 8.10.4 Convergent Technologies 2015 Blood Metabolites Business Region Distribution Analysis Global QYResearch (http://globalqyresearch.com/ ) is the one spot destination for all your research needs. Global QYResearch holds the repository of quality research reports from numerous publishers across the globe. Our inventory of research reports caters to various industry verticals including Healthcare, Information and Communication Technology (ICT), Technology and Media, Chemicals, Materials, Energy, Heavy Industry, etc. With the complete information about the publishers and the industries they cater to for developing market research reports, we help our clients in making purchase decision by understanding their requirements and suggesting best possible collection matching their needs.

Loading Nova Biomedical collaborators
Loading Nova Biomedical collaborators